SCHEDULE 13G: Jorey Chernett Discloses 6.75% Stake in OKYO Pharma Ltd

Jorey Chernett has reported a beneficial ownership of 6.75% of OKYO Pharma Ltd's common stock, totaling 2,301,300 shares, as of May 23, 2025.

Summary

• Jorey Chernett has filed a Schedule 13G indicating beneficial ownership of 2,301,300 shares of OKYO Pharma Ltd's common stock.
• This ownership represents 6.75% of the total class of securities.
• Mr. Chernett holds sole voting power and sole dispositive power over all 2,301,300 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of OKYO Pharma Ltd.

Sentiment

Score: 5

Explanation: The document is a factual report of beneficial ownership and does not contain narrative or performance data to indicate a strong positive or negative sentiment.

Positives

• The disclosure of a significant individual stake (6.75%) by Jorey Chernett could be interpreted as a vote of confidence in OKYO Pharma Ltd's future prospects.
• The certification that the shares are not held for the purpose of changing or influencing control suggests stability and a lack of immediate activist pressure on the company's management.

Future Outlook

na

Industry Context

na

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant individual shareholder and their intent regarding control.

Key Dates

Keywords

OKYO Pharma Ltd, Jorey Chernett, Schedule 13G, Beneficial Ownership, Common Stock, G6724L116